1. Viskin S. Idiopathic polymorphic ventricular tachycardia: a “Benign Disease” with a touch of bad luck? Korean Circ J. 2017; 47:299–306.
Article
2. Cho Y. Management of patients with long QT syndrome. Korean Circ J. 2016; 46:747–752.
Article
3. Schlaich MP, Sobotka PA, Krum H, Lambert E, Esler MD. Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med. 2009; 361:932–934.
Article
4. Ukena C, Mahfoud F, Ewen S, et al. Renal denervation for treatment of ventricular arrhythmias: data from an international multicenter registry. Clin Res Cardiol. 2016; 105:873–879.
Article
5. Hoffmann BA, Steven D, Willems S, Sydow K. Renal sympathetic denervation as an adjunct to catheter ablation for the treatment of ventricular electrical storm in the setting of acute myocardial infarction. J Cardiovasc Electrophysiol. 2013; 24:1175–1178.
Article
6. Kim SS, Kim HK, Park HW, et al. Effect of renal denervation on suppression of PVC and QT prolongation in a porcine model of acute myocardial infarction. Korean Circ J. 2020; 50:38–49.
Article
7. Tzafriri AR, Keating JH, Markham PM, et al. Arterial microanatomy determines the success of energy-based renal denervation in controlling hypertension. Sci Transl Med. 2015; 7:285ra65.
Article
8. Steigerwald K, Titova A, Malle C, et al. Morphological assessment of renal arteries after radiofrequency catheter-based sympathetic denervation in a porcine model. J Hypertens. 2012; 30:2230–2239.
Article
9. Azizi M, Schmieder RE, Mahfoud F, et al. Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial. Lancet. 2018; 391:2335–2345.